Funding sources This study was supported by Abbott Laboratories, Abbott Park, IL, U.S.A.
Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial
Article first published online: 2 NOV 2012
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 167, Issue 6, pages 1374–1381, December 2012
How to Cite
Strober, B.E., Sobell, J.M., Duffin, K.C., Bao, Y., Guérin, A., Yang, H., Goldblum, O., Okun, M.M. and Mulani, P.M. (2012), Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial. British Journal of Dermatology, 167: 1374–1381. doi: 10.1111/bjd.12000
Conflicts of interest B.E.S. has served on the advisory board and as an investigator for Abbott, Amgen, Centocor, Astellas, Novartis, Pfizer, Leo and Genentech and has served on the speakers bureau for Abbott, Amgen, and Johnson and Johnson. J.M.S. has served on the advisory board and speakers bureau and as an investigator for Amgen, Abbott and Centocor. K.C.D. has served as a consultant for Amgen, Eli Lilly, NovoNordisk, VBL and Wyeth/Pfizer; has served on the speakers bureau for Abbott, Amgen and Centocor; and has served as an investigator for Abbott, Amgen, Centocor, Graceway, Incyte, NovoNordisk, Pfizer, VBL and Yaupon. A.G. and H.Y. are employees of Analysis Group, under contract with Abbott Laboratories. Y.B., O.G., M.M.O. and P.M.M. are employees of Abbott Laboratories and hold stock in Abbott Laboratories.
- Issue published online: 26 NOV 2012
- Article first published online: 2 NOV 2012
- Accepted manuscript online: 16 AUG 2012 11:58AM EST
- Accepted for publication 9 August 2012
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.